儿科肠道移植等待名单时间的种族差异并不能通过社会经济措施来解释
Susan A Gutierrez1, Tianna M Truby1, Vikram Raghu2
1Department of Pediatrics, University of California, San Francisco, California, USA.
Pediatric transplantation
|October 13, 2025
概括
儿童肠道移植等待时间仍然存在种族差异,非白人儿童的等待时间明显更长. 这些不平等表明,超越社会经济因素的障碍需要进一步调查,以获得公平的护理.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 移植手术 移植手术
- 健康 公平 研究 健康 公平 研究
背景情况:
- 患有肠衰竭的少数种族儿童面临更高的死亡率和更低的移植率.
- 社会经济因素在移植差异中的作用尚不清楚.
研究的目的:
- 调查儿科肠道移植等待时间和移植后结果的种族差异.
- 评估社会经济因素对这些差异的影响.
主要方法:
- 从移植受体科学注册 (2002-2021) 中对儿科肠道移植受体进行分析.
- 包括来自儿科健康信息系统 (2004-2023) 的住院数据.
- 分析了种族和社区收入,并根据保险状况进行了调整.
主要成果:
- 与白人儿童相比,非白人儿童的等待名单时间 (1034天 vs. 442天) 显着更长.
- 在调整邻里收入和保险后,等待时间的种族差异仍然存在.
- 在住院病床日数,住院风险或30天再入院率方面没有发现显著的种族差异.
结论:
- 儿科肠道移植等待时间的种族差异很大,并不能完全由社会经济因素来解释.
- 可能存在额外的障碍,需要进一步的研究,以确保公平获得移植.
- 需要制定战略来解决不平等问题,并改善所有儿童及时获得移植的机会.
相关概念视频
Kidney Transplant I: Introduction
340
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
340
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
242
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
242
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Bone Marrow Sampling and Transplants
881
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
881
Pharmacokinetics in Pediatric Patients: Drug Distribution
252
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
252
Kidney Transplant II: Surgical Procedure
307
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
307


